Welcome to our dedicated page for Charlottes Web SEC filings (Ticker: CWBHF), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Charlotte's Web Holdings, Inc. files regulatory documents that describe its British Columbia corporate structure, common-share governance, operating and financial results, and material events affecting the hemp-derived CBD wellness business. Its Form 8-K filings include results-of-operations disclosures, material-event reports, board governance items, capital-structure matters, and clinical or regulatory disclosures tied to hemp and cannabinoid products.
The company's proxy materials document annual general and special meeting matters, including director elections, board size, shareholder voting procedures, and governance proposals. Filings also reference investor-rights arrangements affecting board representation and provide formal records of shareholder matters, material agreements, and compensation-related governance disclosures.
Charlotte's Web Holdings, Inc. chief executive officer William J. Morachnick reported equity compensation-related transactions involving common shares and restricted stock units. He exercised derivative awards to acquire 294,661 common shares and the company withheld 71,750 shares to cover tax obligations, a non-market disposition.
After these transactions, he directly held 3,589,362 common shares. His restricted stock unit holdings were 883,986 units, each representing a right to receive one common share. The RSU agreement provides for vesting in equal quarterly installments over 1 year beginning on July 1, 2026, from a grant made on April 1, 2026.
Charlotte's Web Holdings, Inc. director Matthew Evan McCarthy exercised restricted stock units into common shares. On July 1, 2026, 75,000 restricted stock units converted into 75,000 common shares at a stated price of $0.00 per share. Following this equity award vesting and conversion, he now directly holds 150,000 common shares of the company, and the reported restricted stock unit position was reduced to zero.
Charlotte's Web Holdings director Angela May McElwee exercised 85,000 Restricted Stock Units into Common Shares on July 1, 2026. This was a derivative exercise, not an open-market buy or sell. Following the conversion, she directly holds 170,000 Common Shares. Each RSU represented a contingent right to receive one common share, vesting in a single installment on July 1, 2026.
Charlotte's Web Holdings, Inc. director Maureen K. Usifer exercised restricted stock units into 75,000 Common Shares. The Form 4 shows a derivative exercise on July 1, 2026, converting 75,000 restricted stock units into 75,000 Common Shares at a stated price of $0.00 per share, with no sale reported.
Following the transaction, Usifer directly holds 150,000 Common Shares. The derivative line shows 75,000 restricted stock units exercised into an equal number of Common Shares, leaving no remaining units from that grant. Footnotes explain that each unit represented a contingent right to receive one Common Share and that the units vested in a single installment on July 1, 2026.
Charlotte's Web Holdings, Inc. Chief Executive Officer William J. Morachnick reported routine equity compensation activity involving restricted stock units and related tax withholding. He exercised derivative rights to acquire 375,000 common shares at a conversion price of $0.0000 per share.
To cover tax obligations, 91,313 common shares were disposed of at $0.3100 per share as a tax-withholding disposition, rather than an open-market sale. Following these transactions, he directly holds 3,386,014 common shares. The restricted stock units vest in equal quarterly installments beginning on 12/31/2023 under an agreement granted on 10/12/2023.
Charlotte’s Web Holdings, Inc. reports that co‑founder Jared Stanley resigned from its Board of Directors effective June 3, 2026. He will continue to support the company in an advisory capacity, and his decision is stated as not stemming from any disagreement over operations, policies, or financial reporting.
Stanley is dedicating his efforts to leading DeFloria, Inc., a clinical‑stage botanical pharmaceutical company co‑founded by Charlotte’s Web that is developing AJA001, an FDA Phase 2 investigational botanical drug for irritability associated with autism spectrum disorder. Charlotte’s Web is a co‑founder and shareholder of DeFloria and remains involved through this affiliation. Following his resignation, the Board consists of six directors.
Charlotte’s Web Holdings has deepened its strategic relationship with British American Tobacco’s subsidiary BT DE Investments (BAT). BAT invested US$10 million (C$13,873,000) to buy 14,662,765 new common shares at C$0.94 per share and simultaneously converted its existing convertible debenture into equity.
The debenture’s conversion terms were amended, cutting the conversion price from C$2.00 to C$0.94 and setting interest conversion at the same price. BAT converted all principal and accrued interest into 95,281,277 common shares. After the share purchase and conversion, BAT holds 109,944,042 shares, or about 40.6% of the 270,549,931 shares outstanding as of May 28, 2026.
An amended and restated investor rights agreement gives BAT board nomination rights aligned with ownership (with at least two nominees while it holds 10% or more), demand and piggyback registration rights, pre‑emptive and top‑up rights, transfer restrictions, a standstill capping ownership below 49% until May 28, 2028, and consent rights over certain major corporate actions and additional indebtedness above US$10 million.
McElwee Angela May reported acquisition or exercise transactions in this Form 4 filing.
Charlotte's Web Holdings, Inc. director Angela May McElwee received a grant of 85,000 restricted stock units. Each unit represents a contingent right to receive one common share of Charlotte's Web Holdings, Inc.
The grant was made on 6/1/2026 and is scheduled to fully vest on 6/1/2027. Following this award, McElwee holds 85,000 restricted stock units directly, reflecting a compensation-related equity grant rather than an open-market purchase or sale.
McCarthy Matthew Evan reported acquisition or exercise transactions in this Form 4 filing.
Charlotte's Web Holdings, Inc. director Matthew Evan McCarthy reported receiving a grant of 75,000 restricted stock units. Each unit represents a contingent right to receive one common share of Charlotte's Web Holdings, Inc.
The restricted stock units were granted on 6/1/2026 and are scheduled to vest on 6/1/2027. Following this award, McCarthy holds 75,000 restricted stock units directly, reflecting a routine equity-based compensation grant rather than an open-market purchase or sale.
Usifer Maureen K reported acquisition or exercise transactions in this Form 4 filing.
Charlotte's Web Holdings, Inc. director Maureen K. Usifer received a grant of 75,000 restricted stock units on June 1, 2026. Each RSU represents a contingent right to receive one common share of Charlotte's Web Holdings, Inc. The award is scheduled to fully vest on June 1, 2027.
Following this grant, Usifer holds 75,000 restricted stock units directly, all linked to an equivalent number of common shares upon vesting and settlement, subject to the award’s terms.